top of page

Infirst’s treatment for chronic wounds now available on NHS

Infirst Healthcare’s haemoglobin spray granulox, for the treatment of chronic wounds, has been added to the NHS Drug Tariff Part IX, establishing a new Haemoglobin category. The first treatment of its kind, granulox will be available on prescription across the UK from 1st October 2016.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page